Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.20%
SPX
-0.64%
IXIC
-1.15%
FTSE
-0.32%
N225
-0.26%
AXJO
-0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Key Stats

Market Cap
1.34B
Dividend Yield
0.00%
P/E Ratio
-10.79
EPS
-0.48
Revenue
3.92M
Avg. Volume
13.41M

About

What does PGEN do?
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Sector
💻 Health Care
IPO
CEO
Employees
143
Headquarters
Maryland, USA
Website
http://www.precigen.com

Recently from Cashu

publisher logo
Cashu

Precigen Hosts Virtual Chats on FDA-Approved Therapy and Innovative Medical Advancements

2 days ago
publisher logo
Cashu

Precigen Hosts Fireside Chats on Innovative Therapies for Respiratory Papillomatosis

4 days ago
publisher logo
Cashu

Precigen Advances Gene Therapy and Immunotherapy to Transform Cancer Treatment

8 days ago
Stocks
Health Care
pgen
Precigen
NASDAQ: PGEN
-0.02 (-0.55%)
4.525
USD
At close at Aug 29, 20:38 UTC
Summary
News
Signals
Benchmarks
Financials